Celularity Inc. Profile Avatar - Palmy Investing

Celularity Inc.

Celularity Inc., a clinical-stage biotechnology company, develops off-the-shelf placental-derived allogeneic cell therapies for the treatment of cancer, immune, and infectious diseases. It operates through three segments: Cell Therapy, Degenerative Disea…

Biotechnology
US, Florham Park [HQ]
US · Macroeconomic Factors/Risks · Forecasts

Macro

Celularity Inc. mainly operates in US (Alpha-2: US, Alpha-3: USA)

United States
Analysis Results
B Overall Rating
19 Analyzed Indicators
B Annual Indicators Rating
16 Analyzed Indicators
B+ Monthly Indicators Rating
3 Analyzed Indicators
Breakdown

All indicators comes from high quality sources, such as the world bank, OECD, FRED and manuel datasets such as Premiums by Prof. Damodaran.

End of CELU's Analysis
CIK: - CUSIP: 151190105 ISIN: US1511902041 LEI: - UEI: -
Secondary Listings